Triohale Rotacaps 18 Mcg 12 Mcg 400 Mcg

(0 customer reviews)
Price range: $23.00 through $59.00

In Stock

Triohale Rotacaps 18 Mcg 12 Mcg 400 Mcg

Price range: $23.00 through $59.00
In Stock
Secure
Checkout
Free
Shipping
30-Day
Returns
Quality
Guaranteed
Quantity
Safe Payment

All major cards & wallets accepted

Premium Quality

Tested to highest standards

24/7 Support

We're here whenever you need us

Money-Back Guarantee

30-day no questions asked

What Are Triohale Rotacaps 18 Mcg / 12 Mcg / 400 Mcg?

Triohale Rotacaps 18 Mcg / 12 Mcg / 400 Mcg is a prescription-strength, triple-combination inhaled therapy designed for the long-term maintenance management of Chronic Obstructive Pulmonary Disease (COPD) and severe persistent asthma in adults. Manufactured by Cipla Ltd — one of India's most respected pharmaceutical companies — Triohale delivers three clinically complementary active ingredients in a single inhalation device, addressing the root causes of breathing obstruction from multiple angles simultaneously. Unlike single or dual-agent inhalers, Triohale Rotacaps bring together a long-acting anticholinergic (Tiotropium), a long-acting beta-2 agonist (Formoterol), and an inhaled corticosteroid (Ciclesonide) — a combination specifically indicated for patients whose respiratory symptoms remain inadequately controlled by two-drug therapy. This is not a rescue inhaler. Triohale is a maintenance medication taken on a fixed daily schedule to control inflammation, prevent bronchospasm, and sustain open airways over the long term. Browse the complete Inhalers range at Ed Care Store to explore all available respiratory products, including corticosteroid tablets and combination inhalers.

Quick Product Specifications

Product Name Triohale Rotacaps 18 Mcg / 12 Mcg / 400 Mcg
Manufacturer Cipla Ltd
Active Ingredients Tiotropium 18 mcg + Formoterol 12 mcg + Ciclesonide 400 mcg
Drug Class Anticholinergic + LABA + Inhaled Corticosteroid (ICS) Combination
Dosage Form Rotacaps (Dry Powder Capsule for Inhalation via Rotahaler)
Pack Size 30 Rotacaps per packet
Prescription Status Prescription Required
Primary Indication COPD & Severe Asthma (Maintenance Therapy)
Storage Store below 25°C, away from moisture and direct sunlight
 

What Does Triohale Rotacaps Contain? Active Ingredients Explained

Each Triohale Rotacap contains three active pharmaceutical ingredients working together through three distinct and complementary pathways. Understanding what each ingredient does — and why this combination matters — is essential to appreciating why triple therapy is prescribed for moderate-to-severe COPD and refractory asthma.

Tiotropium Bromide — 18 Mcg (Long-Acting Anticholinergic / LAMA)

Tiotropium is a selective, long-acting muscarinic antagonist (LAMA). It works by blocking M3 muscarinic receptors located on the smooth muscle of the bronchial airways. By doing so, it prevents acetylcholine — the neurotransmitter that causes airway muscles to contract — from triggering bronchoconstriction. The result is sustained, 24-hour bronchodilation from a single daily inhalation. Beyond bronchodilation, Tiotropium also reduces mucus secretion and decreases the frequency of COPD exacerbations over time.

Formoterol Fumarate — 12 Mcg (Long-Acting Beta-2 Agonist / LABA)

Formoterol is a long-acting beta-2 adrenergic agonist (LABA) with an important dual characteristic: it provides both a rapid onset of action (similar to short-acting bronchodilators) and an extended duration of up to 12 hours. It stimulates beta-2 receptors on the airway smooth muscle, triggering muscle relaxation and airway widening. Formoterol's rapid onset makes it particularly useful for patients who experience early morning breathlessness — a hallmark symptom of COPD. Together with Tiotropium, it provides dual-mechanism bronchodilation.

Ciclesonide — 400 Mcg (Inhaled Corticosteroid / ICS)

Ciclesonide is an inhaled corticosteroid (ICS) that targets airway inflammation — the underlying driver of both asthma and COPD. Unlike older ICS agents, Ciclesonide is a prodrug: it is converted into its active metabolite (des-ciclesonide) specifically within the lung tissue. This targeted activation means the drug acts predominantly where it is needed most — in the airways — while limiting systemic steroid exposure. Ciclesonide suppresses pro-inflammatory cytokines, reduces airway hyperresponsiveness, and decreases the production of mucus in the bronchial passages. For patients who may also require a corticosteroid in tablet form alongside inhaled therapy, the Omnacortil 40 Mg Tablet (Prednisolone) is also available — often used during acute COPD exacerbations under physician guidance.  

How the Three Ingredients Work Together — At a Glance

Ingredient Drug Class Mechanism Role in Triohale
Tiotropium (18 mcg) Long-Acting Anticholinergic (LAMA) Blocks M3 muscarinic receptors on airway smooth muscle → sustained bronchodilation Opens airways for 24+ hours; reduces mucus secretion
Formoterol (12 mcg) Long-Acting Beta-2 Agonist (LABA) Activates beta-2 adrenergic receptors → rapid and prolonged smooth muscle relaxation Fast-onset bronchodilation; prevents bronchospasm
Ciclesonide (400 mcg) Inhaled Corticosteroid (ICS) Suppresses airway inflammation by inhibiting pro-inflammatory cytokines and mediators Controls underlying inflammation; reduces exacerbation frequency
 

How Do Triohale Rotacaps Work?

Triohale Rotacaps deliver their therapeutic effect through what is called synergistic triple bronchodilation combined with sustained anti-inflammatory action. Because each of the three active ingredients targets a different molecular pathway in the airways, their combined effect is significantly greater than any single agent alone — a concept central to modern triple therapy for COPD.

The Dual Bronchodilation Pathway

Tiotropium and Formoterol act on two completely different receptor systems — the muscarinic (M3) receptors and the beta-2 adrenergic receptors, respectively. Both receptor types are present on airway smooth muscle and both, when activated or blocked appropriately, cause bronchodilation. By engaging both pathways simultaneously, Triohale achieves more complete and sustained bronchodilation than either agent could alone. This is why LAMA + LABA combination is the backbone of moderate-to-severe COPD treatment guidelines globally.

Anti-Inflammatory Control via Ciclesonide

Bronchodilation alone does not address the chronic inflammation that drives COPD progression and triggers asthma attacks. Ciclesonide fills this gap by reducing the underlying inflammatory process in the airway mucosa — decreasing swelling, mucus overproduction, and airway hyperresponsiveness. For patients with COPD and concurrent asthma features, or for those with frequent exacerbations despite dual bronchodilator therapy, the addition of an ICS such as Ciclesonide is clinically recommended.

Why Triple Therapy?

COPD and severe asthma are heterogeneous conditions — meaning different patients have different dominant pathophysiological mechanisms. Triple therapy ensures that regardless of whether a patient's dominant problem is excessive cholinergic tone (Tiotropium addresses this), insufficient adrenergic bronchodilation (Formoterol addresses this), or persistent eosinophilic or neutrophilic inflammation (Ciclesonide addresses this), all three pathways are simultaneously managed. Clinical studies have demonstrated that triple inhaler therapy with a LAMA + LABA + ICS combination results in significantly fewer hospitalisation-requiring exacerbations, better lung function (FEV1 improvement), improved quality of life scores, and reduced all-cause mortality in certain COPD patient populations compared to dual-agent therapy.

What Is Triohale Rotacaps Used For?

Triohale Rotacaps are indicated as maintenance (long-term daily) therapy. They are not designed for acute or sudden breathing difficulties.

Chronic Obstructive Pulmonary Disease (COPD)

This is the primary indication for Triohale Rotacaps. COPD encompasses two overlapping conditions — chronic bronchitis (characterised by persistent airway inflammation and mucus overproduction) and emphysema (characterised by destruction of the alveolar walls and loss of lung elasticity). Triohale is specifically recommended in patients with:
  • Moderate-to-severe or very severe COPD (GOLD Stage II–IV)
  • History of one or more exacerbations in the previous year despite being on dual bronchodilator therapy
  • Elevated blood eosinophil counts suggesting an inflammatory/asthmatic component to their COPD
  • Concurrent features of asthma-COPD overlap syndrome (ACOS)

Severe Persistent Asthma

For adult asthma patients who remain inadequately controlled on a LABA + ICS combination — the standard step 4 treatment — addition of a long-acting anticholinergic (Tiotropium) is recommended. Triohale delivers all three agents together, simplifying this complex regimen into a single device.
  • Symptomatic relief from wheezing, chest tightness, and breathlessness
  • Reduction in the frequency of acute asthma attacks
  • Improvement in morning peak expiratory flow (PEF) and overall lung function
  • Prevention of nocturnal asthma symptoms

What Triohale Rotacaps Are NOT Used For

  • Acute bronchospasm or sudden breathlessness — always use a short-acting rescue inhaler (e.g., Salbutamol) for sudden attacks
  • First-line therapy in newly diagnosed COPD — Triohale is a step-up treatment for more advanced cases
  • Children or adolescents under 18 years of age
Patients managing other chronic health conditions alongside COPD or asthma may also find value in our Men's Health and Women's Health product ranges, available at Ed Care Store.

How to Use Triohale Rotacaps with a Rotahaler — Step-by-Step

Triohale Rotacaps are not swallowed — they must never be taken orally. The capsules are designed exclusively for inhalation using a Rotahaler or compatible dry powder inhaler (DPI) device. Proper technique is essential: poor technique means the medication is deposited in the mouth and throat rather than the lungs, significantly reducing efficacy.

Before You Begin

  • Wash and dry your hands thoroughly
  • Check the Rotahaler is clean and dry
  • Check the capsule — it should be intact, not punctured or broken
  • Never pre-load the capsule until you are ready to inhale

Inhalation Steps

  1. Open the Rotahaler by holding the mouthpiece in one hand and the body in the other, then twist the mouthpiece in the direction indicated until it separates.
  2. Place the Triohale Rotacap into the capsule chamber (the square-shaped compartment at the base of the device). Do not place the capsule in the mouthpiece.
  3. Reassemble the device by twisting the mouthpiece back until you hear a click. This pierces the capsule and prepares the powder for inhalation.
  4. Exhale fully and completely away from the device — do not breathe into the Rotahaler.
  5. Place the mouthpiece firmly between your lips and teeth. Tilt your head back slightly and inhale forcefully and deeply through your mouth in one smooth, sustained breath. You should hear or feel the capsule spinning as the powder is released.
  6. Remove the device from your mouth and hold your breath for 5 to 10 seconds to allow the powder to deposit deep in the airways.
  7. Exhale slowly and gently through your nose. Open the Rotahaler and check the capsule — if powder remains, repeat steps 4 to 6 for a second breath from the same capsule.
  8. Gargle with warm water and spit immediately after use — do not swallow — to prevent oral candidiasis (fungal thrush) caused by Ciclesonide residue in the mouth.
  9. Discard the empty capsule shell. Never reuse or store an opened capsule. Clean the Rotahaler at least once a week with a dry cloth — do not wash with water.

Key Usage Reminders

  • Inhale forcefully — unlike pressurised MDI inhalers, Rotacaps require a strong, rapid breath to disperse the dry powder properly.
  • Never swallow the capsule or its shell — Rotacaps are not oral medications.
  • Store capsules in their original blister pack and only remove each capsule immediately before use — exposure to air and moisture degrades the powder.
  • The capsule shell (made of lactose-coated gelatin) is harmless if small fragments are inhaled — this is normal and expected.

Triohale Rotacaps Dosage: What Is the Right Dose?

Dosage must always be prescribed and confirmed by a qualified respiratory physician. The following information reflects standard clinical practice guidelines:

Standard Adult Dose (18 Years and Above)

  • One Rotacap inhaled twice daily — once in the morning and once in the evening, preferably at the same times each day.
  • Each capsule contains the full triple dose: Tiotropium 18 mcg + Formoterol 12 mcg + Ciclesonide 400 mcg.
  • The total daily dose is therefore: Tiotropium 36 mcg + Formoterol 24 mcg + Ciclesonide 800 mcg.
  • Always use at the scheduled time — do not wait until symptoms appear, as this is a maintenance medicine, not a rescue medicine.

Missed Dose

If you miss a dose, take it as soon as you remember — unless it is almost time for your next scheduled dose, in which case skip the missed dose and continue with your regular schedule. Never double-dose to make up for a missed inhalation.

Overdose

Taking more than the prescribed amount may result in exaggerated side effects including a significantly elevated heart rate, severe tremors, dry mouth, urinary retention, dizziness, and low blood potassium. If you suspect an overdose, contact your physician or seek emergency medical assistance immediately.

Special Populations

  • Elderly Patients: May be used at the standard dose. No dose adjustment is required for age alone, but cardiovascular status should be monitored.
  • Patients with Kidney Impairment: Tiotropium is primarily renally excreted. Patients with moderate-to-severe renal impairment should use Triohale with caution and under close physician monitoring.
  • Patients with Liver Impairment: Formoterol and Ciclesonide are hepatically metabolised. Caution is advised in significant liver disease.
  • Children (Under 18 Years): Not recommended.

What Are the Side Effects of Triohale Rotacaps?

All medications carry a risk of side effects. With Triohale Rotacaps, the majority of side effects are mild, localised, and tend to subside as the body adjusts to the medication. Serious adverse effects are uncommon when the product is used as prescribed.

Common Side Effects (Mild — Usually Resolve Over Time)

  • Dry mouth — especially associated with the anticholinergic effect of Tiotropium
  • Headache
  • Throat irritation or hoarseness of voice — rinse with warm water after each use
  • Oral candidiasis (fungal thrush in the mouth or throat) — prevented by gargling after inhalation
  • Cough following inhalation
  • Sore throat and upper respiratory tract irritation
  • Nausea or mild gastrointestinal discomfort
  • Muscle cramps or musculoskeletal pain
  • Increased heart rate (palpitations) — associated with Formoterol's beta-2 agonist activity
  • Mild tremors — particularly in the hands

Less Common but Clinically Relevant Side Effects

  • Urinary retention or difficulty urinating — due to Tiotropium's anticholinergic effect; of particular concern in men with prostate enlargement (BPH)
  • Constipation
  • Blurred vision or visual disturbances — do not drive if affected
  • Eye pain or increased intraocular pressure — of concern in patients with narrow-angle glaucoma; avoid contact of inhaled spray with the eyes
  • Hypokalemia (low blood potassium) — particularly at higher Formoterol doses; potassium levels should be monitored
  • Hyperglycaemia (elevated blood sugar) — particularly in patients with diabetes
  • Dizziness or lightheadedness

Serious Side Effects — Seek Immediate Medical Attention

  • Paradoxical bronchospasm: Sudden worsening of breathing immediately after inhalation — discontinue use and use a rescue inhaler
  • Acute angle-closure glaucoma: Eye redness, halos around lights, severe eye pain with visual disturbances — requires emergency care
  • Severe allergic reaction (anaphylaxis): Swelling of face, tongue, or throat; hives; severe breathing difficulty
  • Cardiac arrhythmias: Irregular or significantly elevated heart rate beyond normal palpitation
  • Severe hypokalemia with associated muscle weakness
If you experience any eye-related side effects such as blurred vision or increased eye pressure, visit our Eye Care section, where a wide range of supportive Eye Drops and Eye Gel products are available.

Who Should Not Use Triohale Rotacaps? Contraindications and Warnings

Do Not Use Triohale If You Have

  • A known hypersensitivity or allergy to Tiotropium, Formoterol, Ciclesonide, or any excipient (including lactose — if lactose intolerant, inform your doctor)
  • Severe milk protein allergy — the Rotacap carrier contains lactose derived from milk protein
  • Untreated narrow-angle glaucoma — Tiotropium may worsen intraocular pressure
  • Bladder neck obstruction or severe urinary retention not managed with treatment

Use With Caution If You Have

  • Cardiovascular disease — including ischaemic heart disease, hypertension, cardiac arrhythmias, or heart failure (Formoterol has cardiovascular stimulant effects)
  • Diabetes mellitus — both Formoterol and Ciclesonide may elevate blood glucose
  • Hypokalemia — monitor potassium, especially if also taking diuretics
  • Thyroid disorders (hyperthyroidism) — beta-agonist effects may be exaggerated
  • Osteoporosis — long-term use of inhaled corticosteroids at high doses may contribute to bone density reduction
  • Active or inactive tuberculosis, or other chronic or untreated respiratory infections — corticosteroids may suppress immune response
  • Prostatic hyperplasia (enlarged prostate in men) — Tiotropium's anticholinergic effect may worsen urinary symptoms
  • Cataracts — monitor with prolonged ICS therapy

Pregnancy and Breastfeeding

The safety of Triohale Rotacaps during pregnancy has not been fully established through controlled clinical studies. Animal reproductive toxicity data for the combination is limited. Use only if the benefit clearly outweighs the risk as determined by your treating physician. Similarly, the transfer of these active ingredients into breast milk is not fully characterised. If breastfeeding, monitor the infant for anticholinergic signs such as dry mouth, constipation, and urinary problems.

Drug Interactions: What to Tell Your Doctor

Before starting Triohale Rotacaps, inform your prescribing physician of all other medications, supplements, and herbal products you are taking. The following interactions are clinically significant:
  • Beta-blockers (e.g., propranolol, atenolol): Directly antagonise the bronchodilator effect of Formoterol. Non-selective beta-blockers are contraindicated; cardioselective beta-blockers may be used with caution only if absolutely necessary.
  • Other anticholinergic drugs: Co-administration with other anticholinergics (e.g., ipratropium, oxybutynin) may increase the risk of dry mouth, urinary retention, constipation, and increased intraocular pressure.
  • Xanthine derivatives (theophylline, aminophylline): Potentiate the hypokalemic effect of Formoterol; increased cardiac risk.
  • Diuretics (loop and thiazide): Increase the risk of hypokalemia when combined with high-dose Formoterol.
  • MAO inhibitors and tricyclic antidepressants: May potentiate cardiovascular effects of Formoterol — avoid co-administration or use with extreme caution.
  • CYP3A4 inhibitors (e.g., ketoconazole, ritonavir, clarithromycin): May increase systemic exposure to Ciclesonide, increasing the risk of systemic corticosteroid effects.
  • Other sympathomimetics: Additive risk of cardiovascular side effects with Formoterol.
  • Digoxin: Hypokalaemia caused by Formoterol may increase the risk of digoxin toxicity; monitor digoxin levels and potassium.

How to Store Triohale Rotacaps

  • Store at a temperature below 25°C — avoid refrigerating, as cold moisture can affect the dry powder.
  • Keep in a cool, dry place away from direct sunlight, heat sources, and bathroom humidity.
  • Always store capsules in the original blister packaging and remove each capsule only immediately before use.
  • Do not use after the expiry date printed on the packaging.
  • Keep out of reach and sight of children.
  • Do not transfer capsules to other containers or leave them loose in a bag or pocket — they absorb atmospheric moisture rapidly, reducing their effectiveness.
  • If a capsule appears punctured, broken, or discoloured before use, discard it and use a new one.

Why Order Triohale Rotacaps from Ed Care Store?

Ed Care Store is a trusted online health and wellness destination offering a wide selection of genuine, prescription-grade pharmaceutical products across multiple health categories. When you choose to purchase Triohale Rotacaps through our platform, you benefit from:
  • Genuine, manufacturer-verified products from established pharmaceutical manufacturers including Cipla Ltd.
  • Competitive pricing that makes long-term respiratory maintenance therapy more accessible.
  • Discreet and secure packaging with reliable delivery to your door.
  • A comprehensive health store experience spanning respiratory care, eye care, and beyond.
Explore our full product offering in the Ed Care Store online shop or visit our Blog for health guidance and product information relevant to respiratory and general wellness topics. Have questions about Triohale Rotacaps, your order, or any of our products? Contact our team and we will be happy to assist. To learn more about who we are and the standards we uphold, visit the About Us page.

Explore More Health Products at Ed Care Store

Our store covers a broad spectrum of health needs beyond respiratory care. Depending on your health profile, you may also be interested in:
  • Eye Care Capsules — nutritional supplements supporting long-term eye health, particularly useful for patients on long-term corticosteroid therapy where cataract risk may increase.
  • Eye Injections — for patients requiring advanced, targeted ophthalmic treatment.
Medical Disclaimer The content on this page is intended for informational and educational purposes only and does not constitute medical advice, diagnosis, or treatment. Triohale Rotacaps is a prescription medication. Always consult a qualified respiratory physician or healthcare provider before initiating, changing, or stopping this or any other medication. Read the patient information leaflet included with the product before use.

Specifications

Triohale Rotacaps 18 Mcg 30 Rotacap/s, 60 Rotacap/s, 90 Rotacap/s

Frequently Asked Questions

We offer free standard shipping on all orders. Orders are processed within 1-2 business days and typically arrive within 5-7 business days.

We accept returns within 30 days of purchase. Items must be in original condition with tags attached.

Yes! All our products come with a comprehensive warranty against defects in materials or workmanship.

While Formoterol provides onset of action within minutes of the first dose, the full benefit of Triohale — particularly from the Tiotropium and Ciclesonide components — typically develops gradually over days to weeks of regular use. Maximum therapeutic effect on lung function and exacerbation frequency is usually observed after several weeks of consistent daily use. Do not stop using the medication because you do not notice an immediate effect.

No. Stopping Triohale abruptly — even when you feel symptom-free — can cause your underlying condition to worsen significantly. COPD and asthma are chronic conditions requiring consistent long-term management. Always consult your physician before making any changes to your maintenance therapy.

The Rotacap is designed for inhalation only and must not be swallowed. If a capsule is accidentally swallowed whole, the therapeutic effect will be minimal as the drug has very low oral bioavailability. However, contact your physician for guidance if this occurs.

Triohale Rotacaps are not recommended for patients under 18 years of age. Paediatric respiratory conditions are typically managed with age-appropriate formulations and doses under specialist paediatric respiratory care.

Standard asthma inhalers typically contain one or two active ingredients — commonly a LABA + ICS combination (e.g., Formoterol + Budesonide). Triohale adds a third agent (Tiotropium, a LAMA) for patients who require more comprehensive airway control. It is a step-up therapy for more advanced or inadequately controlled disease.

This must be determined by your physician. It is generally inadvisable to use multiple inhalers containing the same class of drug simultaneously (e.g., two different anticholinergics) due to the risk of additive side effects. Always declare all current inhalers to your doctor before starting Triohale.
Triohale Rotacaps 18 Mcg 12 Mcg 400 Mcg
$23.00 – $59.00Price range: $23.00 through $59.00
Triohale Rotacaps 18 Mcg 12 Mcg 400 Mcg – enlarged view
EdCareStore Footer Image

Address
5954 Old Cove Heath Rd Eupora, Mississippi(MS), 39744

US Call/Text
+1 (914) 999-2631

Email
support@edcarestore.com

Trending Products

Vardenafil

Blue Pill

Tadalafil

Oral ED Jelly

Bimatoprost

Shop by category

Shop All

Men’s Health

Women’s Health

Eye Care

Asthma

Diabetes

Company

About Us

Reviews

Medicine Policy

Shipping Policy

Communication Policy

Disclaimer Policy

User guide

Indian Pharmacies

Protect Yourself

Regulated Medicine

Returns & Exchanges

Safe and Secure Shopping

FAQs

Copyright © 2026 Edcarestore | All Rights Reserved

Request Your Free Sample

Fill out the form below and our pharmacist will get in touch!

Please select an option
Full name is required
Valid phone number is required
Valid email address is required
Please describe the sample you're looking for

Thank You!

Your free sample request has been received.

Due to high demand, our pharmacist will reach out to you within the next 3-4 business days.